MX2009004142A - Metodo para prevenir o tratar sindrome metabolico. - Google Patents

Metodo para prevenir o tratar sindrome metabolico.

Info

Publication number
MX2009004142A
MX2009004142A MX2009004142A MX2009004142A MX2009004142A MX 2009004142 A MX2009004142 A MX 2009004142A MX 2009004142 A MX2009004142 A MX 2009004142A MX 2009004142 A MX2009004142 A MX 2009004142A MX 2009004142 A MX2009004142 A MX 2009004142A
Authority
MX
Mexico
Prior art keywords
metabolic syndrome
preventing
treating metabolic
treating
abnormalities
Prior art date
Application number
MX2009004142A
Other languages
English (en)
Inventor
Stephanie K Lynch
Maciej Turowski
Wallace H Yokoyama
Jerry R Conklin
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Publication of MX2009004142A publication Critical patent/MX2009004142A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se pueden usar derivados de celulosa insolubles en agua, tales como etilcelulosa, para tratar o prevenir síndromes metabólicos y/o una de las anormalidades del síndrome metabólico.
MX2009004142A 2006-10-20 2007-10-18 Metodo para prevenir o tratar sindrome metabolico. MX2009004142A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85338906P 2006-10-20 2006-10-20
PCT/US2007/081785 WO2008051793A2 (en) 2006-10-20 2007-10-18 Method of preventing or treating metabolic syndrome

Publications (1)

Publication Number Publication Date
MX2009004142A true MX2009004142A (es) 2009-11-26

Family

ID=39048849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004142A MX2009004142A (es) 2006-10-20 2007-10-18 Metodo para prevenir o tratar sindrome metabolico.

Country Status (8)

Country Link
US (2) US20080176819A1 (es)
EP (1) EP2081647A2 (es)
JP (1) JP2010506956A (es)
CN (1) CN101622032A (es)
AU (1) AU2007309225A1 (es)
CA (1) CA2666936A1 (es)
MX (1) MX2009004142A (es)
WO (1) WO2008051793A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2666670A1 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
JP5033718B2 (ja) * 2008-06-20 2012-09-26 信越化学工業株式会社 ペットサプリメント又はペットフード用組成物
JP2012505661A (ja) * 2008-10-17 2012-03-08 ダウ グローバル テクノロジーズ エルエルシー 水不溶性セルロース誘導体を用いる、トランス脂肪酸の吸収を低減する方法
CN105073782B (zh) 2013-03-13 2018-06-01 株式会社大赛璐 低取代度乙酸纤维素
CN105848500B (zh) 2013-12-20 2020-02-07 株式会社大赛璐 具有脂质代谢改善作用的营养组合物
US10300085B2 (en) * 2014-03-24 2019-05-28 Daicel Corporation Nutritional composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106644A (en) * 1990-05-25 1992-04-21 Procter & Gamble Company Food products containing reduced calorie, fiber containing fat substitute
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
JPH06145050A (ja) * 1992-11-11 1994-05-24 Sekisui Chem Co Ltd 貼付剤の製造方法
AU6728796A (en) * 1995-08-23 1997-03-19 Clive B. Moss High fibre, low calorie, dietary composition
US6200556B1 (en) * 1996-08-22 2001-03-13 Clive B. Moss High fibre, low calorie, dietary composition
CA2228805A1 (en) * 1998-02-04 1999-08-04 Clive B. Moss High fibre, low fat, low calorie, dietary composition
US20030206981A1 (en) * 1999-04-15 2003-11-06 Lotte Confectionery Co., Ltd. Methods of using and compositions comprising cacao extract including dietary fiber
DE10160409A1 (de) * 2001-12-10 2003-06-18 Guenther Beisel Verwendung von ionischen und nichtionischen Celluloseethern zur Herstellung eines gelartigen Mittels zur Verhinderung der Resorption von Fetten aus dem Magen-Darm-Trakt
US6899892B2 (en) * 2001-12-19 2005-05-31 Regents Of The University Of Minnesota Methods to reduce body fat
WO2005021038A2 (de) * 2003-08-27 2005-03-10 Beisel Guenther Mittel zur behandlung des metabolischen syndroms

Also Published As

Publication number Publication date
JP2010506956A (ja) 2010-03-04
US20080176819A1 (en) 2008-07-24
CN101622032A (zh) 2010-01-06
WO2008051793A3 (en) 2008-06-19
WO2008051793A2 (en) 2008-05-02
US20100247664A1 (en) 2010-09-30
CA2666936A1 (en) 2008-05-02
EP2081647A2 (en) 2009-07-29
AU2007309225A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MX342128B (es) Compuestos farmaceuticos.
WO2009089494A3 (en) Pharmaceutical compositions
IN2012DN01869A (es)
WO2010036395A3 (en) Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
EP2068798A4 (en) METHODS, COMPOSITIONS AND APPARATUSES FOR TREATING INJURIES USING ALTERED PRESSURES FROM ATMOSPHERIC PRESSURES
WO2012072713A3 (en) Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae
WO2010062863A3 (en) Compositions containing satiogens and methods of use
MX2010010317A (es) Compuestos heterociclicos novedosos y usos de los mismos.
PL1919466T3 (pl) Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
EP2705850A3 (en) Super fast-acting insulin compositions
WO2011091366A3 (en) Methods of treating or preventing periodontitis and diseases associated with periodontitis
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
MX2009010894A (es) Derivados de 3-hidroquinazolin-4-ona para utilizarse como inhibidores de estearoil-coa-desaturasa.
UA95310C2 (ru) Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
WO2008019372A3 (en) 2-aminobenzoxazole carboxamides as 5ht3 modulators
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
MX2009005114A (es) Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MX2009012920A (es) Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico.
CA2641347C (en) Indazole-heteroaryl derivatives
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.

Legal Events

Date Code Title Description
HH Correction or change in general
HC Change of company name or juridical status
FG Grant or registration